Supernus Pharmaceuticals Stock Forecast - Relative Strength Index
| SUPN Stock | USD 36.85 0.11 0.30% |
Supernus Stock Forecast is based on your current time horizon. Although Supernus Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Supernus Pharmaceuticals' systematic risk associated with finding meaningful patterns of Supernus Pharmaceuticals fundamentals over time.
Supernus |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 56.19 | 56.19 |
| Check Supernus Pharmaceuticals Volatility | Backtest Supernus Pharmaceuticals | Information Ratio |
Supernus Pharmaceuticals Trading Date Momentum
| On December 11 2024 Supernus Pharmaceuticals was traded for 36.85 at the closing time. The top price for the day was 37.28 and the lowest listed price was 36.59 . The trading volume for the day was 253.6 K. The trading history from December 11, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 0.43% . |
| Compare Supernus Pharmaceuticals to competition |
Other Forecasting Options for Supernus Pharmaceuticals
For every potential investor in Supernus, whether a beginner or expert, Supernus Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Supernus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Supernus. Basic forecasting techniques help filter out the noise by identifying Supernus Pharmaceuticals' price trends.Supernus Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Supernus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Supernus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Supernus Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Supernus Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Supernus Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Supernus Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Supernus Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Supernus Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Supernus Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Supernus Pharmaceuticals stock market strength indicators, traders can identify Supernus Pharmaceuticals entry and exit signals to maximize returns.
Supernus Pharmaceuticals Risk Indicators
The analysis of Supernus Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Supernus Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting supernus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.32 | |||
| Semi Deviation | 1.83 | |||
| Standard Deviation | 2.04 | |||
| Variance | 4.16 | |||
| Downside Variance | 4.42 | |||
| Semi Variance | 3.35 | |||
| Expected Short fall | (1.33) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Supernus Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Supernus Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Supernus Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Supernus Stock
Moving against Supernus Stock
| 0.92 | TTOO | T2 Biosystms | PairCorr |
| 0.87 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.86 | AKAN | Akanda Corp | PairCorr |
| 0.83 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.79 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to Supernus Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Supernus Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Supernus Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Supernus Pharmaceuticals to buy it.
The correlation of Supernus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Supernus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Supernus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Supernus Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Supernus Pharmaceuticals to cross-verify your projections. To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Supernus Pharmaceuticals. If investors know Supernus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Supernus Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share 1.07 | Revenue Per Share 11.877 | Quarterly Revenue Growth 0.142 | Return On Assets 0.0289 |
The market value of Supernus Pharmaceuticals is measured differently than its book value, which is the value of Supernus that is recorded on the company's balance sheet. Investors also form their own opinion of Supernus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Supernus Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Supernus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Supernus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Supernus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Supernus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Supernus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.